ADVOCATE | CONNECT | INSPIRE

GEORGIA BIO'S MISSION

is to advance the growth of Georgia’s life sciences industry and foster strategic
partnerships that can create a healthier world

Make Your Voice Be Heard

Georgia Bio is your advocate on the state and federal level to ensure the innovation economy is thriving.

What Interests You?

Ag/Industrial/ Environmental Biotech

Biopharma

Digital Health

Education & Workforce Development

Emerging Companies

Global & Public Health

MedTech & Devices

Students & Young Professionals

Accelerating Life Sciences Across Georgia

Georgia Bio is an independent, non-profit 501(c)(3) trade association whose mission is to advance the growth of Georgia’s life sciences industry and foster strategic partnerships that can create a healthier world. To accomplish this mission, Georgia Bio works on behalf of 200 member organizations to drive public policy, build a network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.

Champion Members

ONE VOICE

Advancing Georgia's Life Sciences IndustrySharing New KnowledgeGrowing the Bottom Line - and the Bioeconomy

Upcoming Events

Webinar: Ramping Down Clinical Trials

Mar 31, 2020 9:00AM—10:00AM

Webinar

Georgia Bioscience & Digital Health Career Fair

Apr 16, 2020 10:00AM—2:00PM

Georgia State University Student Center East
55 Gilmer Street SE
Atlanta, GA 30303

Venture Summit | West

May 05, 2020—May 06, 2020

Santa Clara, CA

View Latest News

GEORGIA STATE SCIENTISTS ARE JOINING THE RACE TO UNRAVEL HOW THE NEW CORONAVIRUS OPERATES — AND FIND EFFECTIVE TREATMENTS.

March 27, 2020

Schools closed. Workers logging in remotely. Streets empty. Businesses shuttered. The coronavirus pandemic is upending daily life throughout the world,…

Read More

FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

March 26, 2020

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases…

Read More

GeoVax Reports 2019 Year-End Financial Results And Provides Corporate Update

March 25, 2020

Recent Pivot to COVID-19 Vaccine Development; Continued Advancements in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, March 25, 2020 – GeoVax…

Read More